Pledging intellectual property for COVID-19

被引：30

作者：

Contreras, Jorge L. ^{[1
,2
]}

Eisen, Michael ^{[3
,4
]}

Ganz, Ariel ^{[5
]}

Lemley, Mark ^{[6
]}

Molloy, Jenny ^{[7
]}

Peters, Diane M. ^{[8
]}

Tietze, Frank ^{[9
]}

机构：

[1] Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA

[2] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA

[3] Howard Hughes Med Inst, Berkeley, CA USA

[4] Univ Calif Berkeley, Berkeley, CA 94720 USA

[5] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA

[6] Stanford Law Sch, Stanford, CA USA

[7] Univ Cambridge, Cambridge, England

[8] Creat Commons, Mountain View, CA USA

[9] Univ Cambridge, Dept Engn, Innovat & IP Management Lab, Cambridge, England

来源：

NATURE BIOTECHNOLOGY | 2020年 / 38卷 / 10期

关键词：

D O I：

10.1038/s41587-020-0682-1

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Voluntary pledges to make intellectual property broadly available to address urgent public health crises can overcome administrative and legal hurdles faced by more elaborate legal arrangements such as patent pools and achieve greater acceptance than governmental compulsory licensing.

引用

页码：1146 / 1149

页数：4

共 50 条

[11] Waiver of Intellectual Property Rights on COVID-19 vaccine roll out
Cabatbat, Katherine Pia M.
[J]. JOURNAL OF PUBLIC HEALTH, 2022, 44 (02) : E338 - E338
[12] COVID-19: save lives with open intellectual-property licences
Jorge L. Contreras
Michael Eisen
Diane M. Peters
[J]. Nature, 2020, 583 : 683 - 683
[13] The Medical Right to Repair: Intellectual Property, the Maker Movement, and COVID-19
Rimmer, Matthew
[J]. SUSTAINABILITY, 2023, 15 (20)
[14] COVID-19: save lives with open intellectual-property licences
Contreras, Jorge L.
Eisen, Michael
Peters, Diane M.
[J]. NATURE, 2020, 583 (7818) : 683 - 683
[15] A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property
Kasapcopur, Ozgur
[J]. TURKISH ARCHIVES OF PEDIATRICS, 2021, 56 (04): : 283 - 284
[16] Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic
Altindis, Emrah
[J]. EXPERT REVIEW OF VACCINES, 2022, 21 (04) : 427 - 430
[17] Crisis-Critical Intellectual Property: Findings From the COVID-19 Pandemic
Tietze, Frank
Vimalnath, Pratheeba
Aristodemou, Leonidas
Molloy, Jenny
[J]. IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2022, 69 (05) : 2039 - 2056
[18] Intellectual property waiver for covid-19 vaccines will advance global health equity
Erfani, Parsa
Binagwaho, Agnes
Jalloh, Mohamed Juldeh
Yunus, Muhammad
Farmer, Paul
Kerry, Vanessa
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
[19] Intellectual Property and Competition Law in the Pharmaceutical Sector during the covid-19 Pandemic
Horna, Pierre
Garcia, Ray Meloni
Antonioli, Dante Mendoza
Macedo, Jose Antonio Pejoves
Varsi-Rospigliosi, Enrique
[J]. ACTA BIOETHICA, 2024, 30 (01) : 129 - 145
[20] The Negative Effect of Share Pledging by Controlling Shareholders under COVID-19
Zheng, Dengjin
Dai, Xin
Lan, Tianqi
Zhang, Wei
Mou, Jian
[J]. EMERGING MARKETS FINANCE AND TRADE, 2021, 57 (10) : 2826 - 2837

← 1 2 3 4 5 →